RBA Form 4: Director Sieger records 11 dividend-equivalent awards
Rhea-AI Filing Summary
Michael D. Sieger, a director of RB Global Inc. (ticker: RBA), reported on Form 4 that on 09/18/2025 he acquired dividend equivalent rights tied to deferred share units and to a 2025 restricted share unit (RSU) grant. The filing records an acquisition of 6 dividend equivalent rights related to deferred share units and 5 dividend equivalent rights related to 2025 RSUs; each right represents a contingent entitlement to the economic equivalent of one RBA common share and were acquired at a price of $0. The reported ownership form for both items is direct. The form shows 52 and 10 derivative securities beneficially owned following the respective transactions. The filing was signed by an attorney-in-fact on behalf of Mr. Sieger on 09/19/2025.
Positive
- Acquisition of 11 dividend equivalent rights (6 and 5) indicating continued alignment of director compensation with shareholder value
- No cash outlay for the acquired dividend equivalent rights (price reported as $0), reflecting compensation issuance rather than market purchases
Negative
- None.
Insights
TL;DR: Routine executive compensation accruals; no cash consideration and limited share equivalents, so minimal immediate dilution.
The Form 4 documents non-cash acquisitions of dividend equivalent rights tied to deferred share units and RSUs, totaling 11 contingent share equivalents acquired on 09/18/2025. These awards are compensation-related and become payable in line with the underlying deferred units and RSUs, which limits immediate market impact. Reported post-transaction beneficial holdings of 52 and 10 derivative securities suggest modest insider exposure but do not indicate disposition or cash proceeds. For governance assessment, this is a standard disclosure of director compensation rather than material corporate action.
TL;DR: Compliance filing records acquisition of contingent dividend equivalents; appears routine and consistent with Rule 16 reporting.
The filing clearly states the transaction codes as acquisitions at a price of $0, and includes the required explanatory footnotes about the timing and linkage of dividend equivalent rights to deferred share units and 2025 RSUs. The form is signed by an attorney-in-fact, with filing dates provided. There are no sales, exercised options, or transfers reported here, so the disclosure meets Section 16 reporting requirements without indicating unusual insider trading activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights (DSUs) | 6 | $0.00 | -- |
| Grant/Award | Dividend Equivalent Rights (2025 RSUs) | 5 | $0.00 | -- |
Footnotes (1)
- The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
